Lifitegrast in Treatment of Dry Eye Disease—A Practical, Narrative Expert Review
Conclusions: Based on the current literature, we conclude that lifitegrast could improve various parameters of DED. Still, larger controlled trials are required to establish additional benefits of this medication beyond those of other DED treatments.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/joph/6504111 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|